Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

Hypertension. 2008 Feb;51(2):168-71. doi: 10.1161/HYPERTENSIONAHA.107.090514. Epub 2007 Dec 17.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adrenergic Antagonists / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Humans
  • Hypertension / etiology
  • Hypertension / physiopathology*
  • Hypertension / therapy*
  • Obesity / complications*
  • Obesity / therapy
  • Sympathetic Nervous System / physiopathology*
  • Sympatholytics / therapeutic use
  • Weight Loss

Substances

  • Adrenergic Antagonists
  • Antihypertensive Agents
  • Sympatholytics